| 英文名称 |
中文名称 |
CAS |
|
4-(trifluoromethyl)nicotinic acid
|
氟啶虫酰胺中间体 |
158063-66-2 |
|
Afatinib Impurity A
|
阿法替尼杂质A |
|
|
Afatinib Impurity C
|
阿法替尼杂质 |
|
|
Afatinib Impurity D
|
阿法替尼杂质 |
|
|
Afatinib Impurity E
|
阿法替尼杂质 |
|
|
Afatinib Impurity F
|
阿法替尼杂质 |
|
|
Afatinib Impurity G
|
阿法替尼杂质 |
|
|
Afatinib Impurity H
|
阿法替尼杂质 |
|
|
Afatinib Impurity I
|
阿法替尼杂质 |
1637254-93-3 |
|
Afatinib Impurity J
|
阿法替尼杂质 |
1456696-14-2 |
|
Alogliptin Impurity 1
|
阿格列汀杂质1 |
|
|
Alogliptin Impurity 10
|
阿格列汀杂质10 |
|
|
Alogliptin Impurity 2
|
阿格列汀杂质2 |
|
|
Alogliptin Impurity 3
|
阿格列汀杂质3 |
|
|
Alogliptin Impurity 4
|
阿格列汀杂质4 |
|
|
Alogliptin Impurity 5
|
阿格列汀杂质5 |
|
|
Alogliptin Impurity 6
|
阿格列汀杂质6 |
|
|
Alogliptin Impurity 7
|
阿格列汀杂质7 |
|
|
Alogliptin Impurity 8
|
阿格列汀杂质8 |
|
|
Alogliptin Impurity 9
|
阿格列汀杂质9 |
|
|
Crisaborole
|
克瑞沙硼 |
906673-24-3 |
|
Dacomitinib
|
达克替尼 |
1110813-31-4 |
|
N-((1S)-1-(1-Naphthyl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine
|
西那卡赛S异构体 |
694495-47-1 |
|
N-Cyanomethyl-4-trifluoromethyl-3-pyridinecarboxamide
|
氟啶虫酰胺 |
158062-67-0 |
|
R-afatinib
|
阿法替尼手性异构体杂质 |
945553-91-3 |
|
Rivaroxaban Impurity A
|
利伐沙班杂质A |
1415566-28-7 |
|
Rivaroxaban Impurity C
|
利伐沙班杂质C |
1365267-35-1 |
|
Rivaroxaban Impurity D
|
利伐沙班杂质D |
97799-98-9 |
|
Rivaroxaban Impurity E
|
利伐沙班杂质E |
88777-57-5 |
|
Rivaroxaban Impurity F
|
利伐沙班杂质F |
550-44-7 |
|
Rivaroxaban Impurity G
|
利伐沙班杂质G |
721401-53-2 |
|
Rivaroxaban Impurity J
|
利伐沙班杂质J |
1151893-81-0 |
|
Rivaroxaban Impurity M
|
利伐沙班杂质M |
181140-34-1 |
|
R-Rivaroxaban
|
利伐沙班杂质手性异构体杂质 |
865479-71-6 |
|
SILYBIN
|
水飞蓟宾 |
22888-70-6 |
|
3-(trifluoromethyl)-5-(4-methyl-1H-imidazol-1-yl)benzenamine
|
尼罗胺 |
641571-11-1 |
|
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid
|
尼罗酸 |
641569-94-0 |
|
4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide
|
尼罗替尼碱 |
641571-10-0 |
|
Afatinib Impurity B
|
阿法替尼杂质 |
314771-76-1 |
|
7-Hydroxy-6-methoxy-3,4-dihydroquinazolin-4-one
|
凡德中间体 |
162012-72-8 |
|
Afatinib
|
阿法替尼 |
850140-72-6 |
|
Ibrutinib
|
伊布鲁替尼 |
936563-96-1 |
|
N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide
|
伊布鲁替尼中间体 |
302964-08-5 |
|
vandetanib
|
凡德他尼 |
443913-73-3 |
|
Rivaroxaban Impurity I
|
利伐沙班杂质I |
1082495-22-4 |
|
Rivaroxaban Impurity H
|
利伐沙班杂质H |
1807455-76-0 |
|
Rivaroxaban Impurity K
|
利伐沙班杂质K |
|
|
Rivaroxaban Impurity L
|
利伐沙班杂质L |
|
|
S-Alogliptin
|
阿格列汀手性异构体杂质 |
|
|
Mubritinib
|
莫立替尼 |
366017-09-6 |
|
Afatinib dimaleate
|
阿法替尼二马来酸盐 |
850140-73-7 |
|
4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide,hydrate,hydrochloride
|
尼罗替尼盐酸盐一水合物 |
923288-90-8 |
